Pharmacological characterization of VIP receptors in human lung membranes
- 1 March 1988
- Vol. 9 (2), 339-345
- https://doi.org/10.1016/0196-9781(88)90270-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Interaction of vasoactive intestinal peptide (VIP) and N‐terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranesEuropean Journal of Biochemistry, 1986
- Autoradiographic localisation of VIP receptors in human lungFEBS Letters, 1986
- Characterisation of a high-affinity VIP receptor in human lung parenchymaFEBS Letters, 1986
- Primary structure of helodermin, a VIP‐secretin‐like peptide isolated from Gila monster venomFEBS Letters, 1984
- Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross‐linkingEuropean Journal of Biochemistry, 1984
- Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological propertiesFEBS Letters, 1984
- Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP‐ and secretin‐like properties (helodermin) from Gila monster venomFEBS Letters, 1984
- Asbestos-related increase in pulmonary levels of vasoactive intestinal peptide (VIP)Life Sciences, 1983
- Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranesBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Vasoactive Intestinal Peptide: A Possible Transmitter of Nonadrenergic Relaxation of Guinea Pig AirwaysScience, 1980